CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.
about
Biomarkers of therapeutic response in multiple sclerosis: current statusMicrowave & Magnetic (M2) Proteomics of a Mouse Model of Mild Traumatic Brain Injury.Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.Texture analyses of quantitative susceptibility maps to differentiate Alzheimer's disease from cognitive normal and mild cognitive impairment.Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability?Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritisLevels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction.Neurofilament light chain level is a weak risk factor for the development of MS.Molecular biomarkers of neurodegeneration.Body fluid biomarkers for multiple sclerosis--the long road to clinical application.Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.Serum retinol levels are associated with brain volume loss in patients with multiple sclerosis.N-acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis.Fluid biomarker and electrophysiological outcome measures for progressive MS trials.Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosis.Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity.Science is 1% inspiration and 99% biomarkers.Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis.Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis studyThe only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level—NO
P2860
Q27012726-20451AA6-FB94-4EBD-8427-9C83C224F593Q30656777-128E46F1-4158-4E0B-BEC3-B689464C42A1Q30712257-189A85AE-6B04-465C-9355-2DA8F303ACCFQ31119377-34CEB9F9-EA7D-40A1-B304-186C4F30ADC7Q34570124-4F9AA911-7AB7-44E6-87BD-128BDF8CFCB3Q35000781-B720411B-253D-4E40-98BA-A3BB9B4300C5Q35015106-E78DAF8C-380D-4E28-AF28-4E69D1B8804DQ35759095-15F2E51C-7747-4255-A30C-28F0972B38B4Q37265143-C81648FE-05D4-4788-979F-689D077873D4Q38154930-8FE375F3-460C-4000-AAE2-5EFE742134F8Q38590773-462FD258-071C-4055-BAFC-6A5BBF30D32EQ38682945-650EDE73-561A-4E0F-94B9-753110C5F899Q38984981-CD95215C-EABC-4CF8-A563-361D5018C4BDQ39035274-1FCA23C6-415C-463D-8343-4438212833C8Q41078810-DD0A4FAA-46BE-4953-B861-84494A5C7212Q42683530-65337B86-C4B1-4E29-BC13-B366D0AF39EEQ47638443-D7CB649A-9D1A-44A2-9BDC-43C47185A078Q48488486-91714AD9-D9D1-4B07-ACA1-6234D63794DDQ49015259-A78D9B6F-F4B5-4D32-B65D-74A9E8CBF86AQ50984144-961E3656-B00B-4B5A-9987-FD9189996C12Q52093939-BA072DFE-3878-4DB6-904A-6A7572C9D678Q57161829-CF77B557-4F31-4D45-B8FA-3683BA9CCF3BQ57601807-6B304F5A-5C30-4632-9061-42299D935BC0
P2860
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
CSF neurofilament and N-acetyl ...... clinically isolated syndrome.
@en
type
label
CSF neurofilament and N-acetyl ...... clinically isolated syndrome.
@en
prefLabel
CSF neurofilament and N-acetyl ...... clinically isolated syndrome.
@en
P2093
P2860
P50
P356
P1476
CSF neurofilament and N-acetyl ...... clinically isolated syndrome.
@en
P2093
C Enzinger
C Langkammer
G Bachmaier
J-J Archelos
M A Blankenstein
M J A Koel-Simmelink
M L G Vane
M Wallner-Blazek
P2860
P304
P356
10.1177/1352458512458010
P577
2012-08-23T00:00:00Z